Article
Study on NGS-based molecular profiling of malignant pleural effusion supernatant cfDNA in guiding targeted therapy for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) - 1 Jul 2026
Wang Yuan, Liang Shuo, Zhang Jia-Meng, Sun Zi-Han, Li Wei-Hua, Sun Yue, Wang Cong, Chang Xin-Xiang, Zhao Lin-Lin, Zhao Huan, Guo Hui-Qin, Zhang Zhi-Hui
Abstract excerpt
BACKGROUND: For patients with advanced non-small cell lung cancer (NSCLC), obtaining histological specimens can be challenging due to the presence of malignant pleural effusion (MPE), making liquid biopsy an important alternative for molecular profiling. This study aims to comparatively analyze the advantages of MPE supernatant over other sample types in molecular testing and to assess the feasibility and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
